Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ChemedSTU:CXM +2.67%69 14-Day RSI is 72.79 as of Jul. 31, 2026. GuruFocus rates STU:CXM with a GF Score™ of 69/100 and a GF Value™ of €589.57 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 698 Healthcare Providers & Services companies, Chemed ranks worse than 98.28% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-31), Chemed's 14-Day RSI is 72.79.
The industry rank for Chemed's 14-Day RSI or its related term are showing as below:
STU:CXM's 14-Day RSI is ranked worse than 98.28% of 698
companies
in the Healthcare Providers & Services industry
Industry Median: 48.765
vs STU:CXM: 72.79
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Chemed 14-Day RSI Related Terms
STU:CXM vs PACS, LFST, UHS: 14-Day RSI Comparison
For the Medical Care Facilities subindustry, Chemed's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chemed 14-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Chemed's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Chemed's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chemed (STU:CXM) has a 14-Day RSI of 72.79 as of Jul. 31, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Chemed and its competitors. According to the industry distribution chart, Chemed ranks #686 out of 698 companies in the Healthcare Providers & Services industry, placing it in the top 98.3%.
Is Chemed's 14-Day RSI too high?
Chemed's current 14-Day RSI is 72.79. The Healthcare Providers & Services industry median 14-Day RSI is 48.77. Chemed's value of 72.79 is 49.3% above this industry median. Based on the distribution chart, Chemed ranks #686 out of 698 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Chemed has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chemed's 14-Day RSI compare to PACS and LFST?
According to the Healthcare Providers & Services industry distribution chart, Chemed ranks #686 out of 698 companies for 14-Day RSI. This places Chemed in the lower half of its industry. The industry median 14-Day RSI is 48.77. Chemed's value of 72.79 is 49.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Healthcare Providers & Services company?
The median 14-Day RSI among Healthcare Providers & Services companies is 48.77, based on 698 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chemed's current 14-Day RSI of 72.79 is 49.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Chemed and its competitors. For the Healthcare Providers & Services industry, the median 14-Day RSI is 48.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chemed's current 14-Day RSI is 72.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemed stock overvalued right now?
Based on GuruFocus' analysis, Chemed (STU:CXM) is currently considered Modestly Undervalued. The stock's GF Value™ is €589.57, compared to a current price of €462.00 — trading 21.6% below its estimated fair value. The current 14-Day RSI is 72.79 and 49.3% above the Healthcare Providers & Services industry median of 48.77. Chemed's overall GF Score™ is 69/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Chemed (STU:CXM), the current 14-Day RSI is 72.79 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chemed (STU:CXM) Overvalued in 2026?
Based on GuruFocus' analysis, Chemed stock appears to be undervalued.
The current stock price of €462.00 is trading 21.6% below its estimated GF Value™ of €589.57.
GuruFocus considers Chemed to be Modestly Undervalued.
Key valuation signals for STU:CXM:
14-Day RSI: 72.79
GF Value™: €589.57 vs. price of €462.00 (21.6% below fair value)
Industry Position: 49.3% above the Healthcare Providers & Services median (#686 of 698)
No single metric tells the full story. See the STU:CXM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
69GF Score
Get the complete analysis for STU:CXM
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:CXM has been successfully added to your 
